atai Life Sciences is a clinical-stage biopharmaceutical company developing psychedelic and related therapies for depression and other mental health disorders.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Louis Bacon / Moore | 55 | Holds (flat) | 952,380 | $5,038,090 | 0.1% |
| Ruane Cunniff / Sequoia Fund | 71 | Holds (flat) | 42,112 | $222,772 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.